Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trial
| Image |  |
|---|---|
| Description | scientific article published on 28 January 2020 |
| Author/s |
author: Michael C Wehr Berthold Langguth |
| Publication date | January 28, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |